A PHASE II, RANDOMIZED STUDY OF ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) AND TRASTUZUMAB IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN (XELOX) IN PATIENTS WITH HER2 POSITIVE LOCALLY ADVANCED RESECTABLE GASTRIC CANCER OR ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION (GEJ)
| Title | A PHASE II, RANDOMIZED STUDY OF ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) AND TRASTUZUMAB IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN (XELOX) IN PATIENTS WITH HER2 POSITIVE LOCALLY ADVANCED RESECTABLE GASTRIC CANCER OR ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION (GEJ) |
|---|---|
| Description | Study-A PHASE II, RANDOMIZED STUDY OF ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) AND TRASTUZUMAB IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN (XELOX) IN PATIENTS WITH HER2 POSITIVE LOCALLY ADVANCED RESECTABLE GASTRIC CANCER OR ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION (GEJ) -genetic data Copy number of HER2 in circulating tumor DNA, no sequencing involved |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA017352 |
| Release Date | 2023-05-31 |
| Submitter | lin shen (linshenpku@163.com) |
| Organization | Beijing Cancer Hospital |
| Submission Date | 2023-05-30 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004235-01 | Her2 Copy number of ctDNA no sequencing involved | 42 | Other Type of Genomic Data | 1.1 MB | xls | 0 | Unavailable |